Preptin: A New Bone Metabolic Parameter?
Open Access
- 4 September 2023
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 13 (9) , 991
Abstract
Preptin is a 34-aminoacid peptide derived from the E-peptide of pro-insulin-like growth factor 2 (pro-IGF2) that is co-secreted with insulin and upregulates glucose-mediated insulin secretion. High serum preptin levels were described in conditions associated with insulin resistance, such as polycystic ovary syndrome and type 2 diabetes mellitus (T2M). Insulin and also IGF2 are known to be anabolic bone hormones. The “sweet bone” in T2M usually associates increased density, but altered microarchitecture. Therefore, preptin was proposed to be one of the energy regulatory hormones that positively impacts bone health. Experimental data demonstrate a beneficial impact of preptin upon the osteoblasts. Preptin also appears to regulate osteocalcin secretion, which in turn regulates insulin sensitivity. Preptin is greatly influenced by the glucose tolerance status and the level of physical exercise, both influencing the bone mass. Clinical studies describe low serum preptin concentrations in osteoporosis in both men and women, therefore opening the way towards considering preptin a potential bone anabolic therapy. The current review addresses the relationship between preptin and bone mass and metabolism in the experimental and clinical setting, also considering the effects of preptin on carbohydrate metabolism and the pancreatic–bone loop.Keywords
This publication has 103 references indexed in Scilit:
- Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formationBMC Musculoskeletal Disorders, 2013
- The Relationship between Serum Osteocalcin Concentration and Glucose Metabolism in Patients with Type 2 Diabetes MellitusInternational Journal of Endocrinology, 2013
- The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin levelReproductive Biology and Endocrinology, 2012
- Activation of β-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in boneBone, 2010
- Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy MetabolismCell, 2010
- Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body CompositionCell, 2010
- Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone HomeostasisMolecular and Cellular Biology, 2010
- Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblastsAmino Acids, 2009
- High glucose induces adipogenic differentiation of muscle-derived stem cellsProceedings of the National Academy of Sciences, 2008
- OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?Clinical Rheumatology, 2004